Outcomes for liver transplant candidates listed with low model for end-stage liver disease score

被引:39
作者
Kwong, Allison J. [1 ]
Lai, Jennifer C. [3 ]
Dodge, Jennifer L. [2 ]
Roberts, John P. [2 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA
关键词
HIGH-RISK; MORTALITY; CIRRHOSIS; DEATH; MELD; PREDICTION; ALLOCATION; ASCITES;
D O I
10.1002/lt.24307
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Model for End-Stage Liver Disease (MELD) score, which estimates mortality within 90 days, determines priority for liver transplantation (LT). However, longer-term outcomes on the wait list for patients who are initially listed with low MELD scores are not well characterized. All adults listed for primary LT at a single, high-volume center from 2005 to 2012 with an initial laboratory MELD score of 22 or lower were evaluated. Excluded were those patients listed with MELD exception points who underwent living donor liver transplantation (LDLT) or transplantation at another center, or who were removed from the wait list for nonmedical reasons. Outcomes and causes of death were identified by United Network for Organ Sharing, the National Death Index, and an electronic medical record review. Multivariate competing risk analysis evaluated predictors of death compared to deceased donor liver transplantation (DDLT); 893 patients were listed from 2005 to 2012. By the end of follow-up, 27% had undergone DDLT, and 31% were removed from the wait list for death or clinical deterioration. In a competing risks assessment, only MELD score of 6-9, older age, lower serum albumin, lower body mass index, and diabetes conferred an increased risk of wait-list dropout compared to DDLT. Listing for simultaneous liver-kidney transplantation was protective against wait-list dropout. Of the patients included, 275 patients died or were delisted for being too sick; 87% of the identifiable causes of death were directly related to end-stage liver disease or hepatocellular carcinoma. In conclusion, patients with low listing MELD scores remain at a significant risk for death due to liver-related causes and may benefit from early access to transplantation, such as LDLT or acceptance of high-risk donor livers. Predictors of death compared to transplantation may allow for early identification of patients who are at risk for wait-list mortality. Liver Transpl 21:1403-1409, 2015. (c) 2015 AASLD.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 50 条
[31]   The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortality [J].
Al-Freah, Mohammad A. B. ;
Gane, Edward J. ;
Livingstone, Vicki ;
McCall, John ;
Munn, Stephen .
HEPATOLOGY INTERNATIONAL, 2012, 6 (02) :491-497
[32]   Impact of Model for End-stage Liver Disease Score in Post-Liver Transplantation Prognosis [J].
Annunziata, T. B. ;
Paulino, K. ;
Fernandes, R. ;
Bento, G. ;
Stoduto, G. ;
Vasconcelos, R. ;
Demetrio, L. ;
Moreira, L. F. P. .
TRANSPLANTATION PROCEEDINGS, 2016, 48 (07) :2348-2351
[33]   Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation [J].
Raza, Muhammad H. ;
Kwon, Yong ;
Kobierski, Pierre ;
Misra, Asish C. ;
Lim, Angelina ;
Goldbeck, Cameron ;
Etesami, Kambiz ;
Kohli, Rohit ;
Emamaullee, Juliet .
LIVER TRANSPLANTATION, 2023, 29 (02) :134-144
[34]   The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single- center study [J].
Lee, Doo-Ho ;
Park, Yeon Ho ;
Choi, Seok Won ;
Nam, Kug Hyun ;
Choi, Sang Tae ;
Kim, Doojin .
ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 101 (06) :360-367
[35]   Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score [J].
Hu, Zhenhua ;
Zhou, Jie ;
Li, Zhiwei ;
Xiang, Jie ;
Zhang, Qijun ;
Yan, Sheng ;
Wu, Jian ;
Zhang, Min ;
Wang, Weilin ;
Zheng, Shusen .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2017, 24 (04) :206-216
[36]   The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass [J].
Krafcik, Brianna M. ;
Farber, Alik ;
Eslami, Mohammad H. ;
Kalish, Jeffrey A. ;
Rybin, Denis ;
Doros, Gheorghe ;
Shah, Nishant K. ;
Siracuse, Jeffrey J. .
JOURNAL OF VASCULAR SURGERY, 2016, 64 (01) :124-130
[37]   Preoperative model for end-stage liver disease score as a predictor for posthemihepatectomy complications [J].
Alghamdi, Thamer ;
Abdel-Fattah, Muataz ;
Zautner, Andreas ;
Lorf, Thomas .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (06) :668-675
[38]   Stage of Cirrhosis Predicts the Risk of Liver-Related Death in Patients With Low Model for End-Stage Liver Disease Scores and Cirrhosis Awaiting Liver Transplantation [J].
Wedd, Joel ;
Bambha, Kiran M. ;
Stotts, Matt ;
Laskey, Heather ;
Colmenero, Jordi ;
Gralla, Jane ;
Biggins, Scott W. .
LIVER TRANSPLANTATION, 2014, 20 (10) :1193-1201
[39]   Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts [J].
Lucidi, Cristina ;
Corradini, Stefano Ginanni ;
Abraldes, Juan G. ;
Merli, Manuela ;
Tandon, Puneeta ;
Ferri, Flaminia ;
Parlati, Lucia ;
Lattanzi, Barbara ;
Poli, Edoardo ;
Di Gregorio, Vincenza ;
Farcomeni, Alessio ;
Riggio, Oliviero .
LIVER TRANSPLANTATION, 2016, 22 (10) :1333-1342
[40]   Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease [J].
Lai, Yan-Hua ;
Duan, Wei-Dong ;
Yu, Qiang ;
Ye, Sheng ;
Xiao, Nian-Jun ;
Zhang, Dong-Xin ;
Huang, Zhi-Qiang ;
Yang, Zhan-Yu ;
Dong, Jia-Hong .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (20) :6296-6303